Botox has been used in Children to treat spasticity.  This recent news is something all parents should look at before considering using botox to treat spasticity in children with cerebral palsy.

The Food and Drug Administration issued a warning that Allergan’s Botox and Botox Cosmetic as well as Solstice Neuroscience’s Myobloc have been linked to adverse reactions including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses.

The agency said the reactions may be related to overdosing and were found in both FDA-approved and nonapproved usages, but there is no evidence that they’re related to any defect in the products.

The most severe adverse effects were found in children treated for spasticity in their limbs associated with cerebral palsy, which isn’t an FDA-approved use of botulism toxins in children or adults.

The agency is currently reviewing safety data from clinical studies submitted by the drugs’ manufacturers, as well as post-marketing adverse event reports and medical literature.

Sources:

The Street.com | Consumer Affairs

Tags: botox spasticity FDA warning